NEUROONE MEDICAL TECHNOLOGIE (NMTC) Stock Price & Overview
NASDAQ:NMTC • US64130M2098
Current stock price
The current stock price of NMTC is 4.45 USD. Today NMTC is up by 501.35%. In the past month the price increased by 1.12%. In the past year, price increased by 27.69%.
NMTC Key Statistics
- Market Cap
- 225.571M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -0.17
- Dividend Yield
- N/A
NMTC Stock Performance
NMTC Stock Chart
NMTC Technical Analysis
ChartMill assigns a technical rating of 3 / 10 to NMTC. When comparing the yearly performance of all stocks, NMTC turns out to be only a medium performer in the overall market: it outperformed 45.95% of all stocks.
NMTC Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to NMTC. NMTC scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
NMTC Earnings
On February 17, 2026 NMTC reported an EPS of -0.03 and a revenue of 2.89M. The company beat EPS expectations (26.47% surprise) and beat revenue expectations (5.88% surprise).
NMTC Forecast & Estimates
9 analysts have analysed NMTC and the average price target is 2.07 USD. This implies a price decrease of -53.39% is expected in the next year compared to the current price of 4.45.
For the next year, analysts expect an EPS growth of -57.25% and a revenue growth 28.8% for NMTC
NMTC Groups
Sector & Classification
NMTC Financial Highlights
Over the last trailing twelve months NMTC reported a non-GAAP Earnings per Share(EPS) of -0.17. The EPS increased by 36.62% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -79.61% | ||
| ROE | -106.67% | ||
| Debt/Equity | 0.13 |
NMTC Ownership
NMTC Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 16.57 | 176.478B | ||
| ISRG | INTUITIVE SURGICAL INC | 44.58 | 166.347B | ||
| SYK | STRYKER CORP | 22.32 | 130.688B | ||
| BSX | BOSTON SCIENTIFIC CORP | 18.3 | 96.022B | ||
| IDXX | IDEXX LABORATORIES INC | 38.8 | 46.124B | ||
| EW | EDWARDS LIFESCIENCES CORP | 25.84 | 45.085B | ||
| BDX | BECTON DICKINSON AND CO | 11.36 | 44.283B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 14.16 | 33.542B | ||
| RMD | RESMED INC | 18.49 | 33.332B | ||
| DXCM | DEXCOM INC | 24.17 | 23.684B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 11.14 | 18.234B | ||
| HOLX | HOLOGIC INC | 15.48 | 16.969B | ||
| PODD | INSULET CORP | 31.22 | 14.256B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About NMTC
Company Profile
NeuroOne Medical Technologies Corp. is a medical technology company, which engages in diagnostics, ablations, and deep brain stimulation technology for brain-related conditions. The company is headquartered in Eden Prairie, Minnesota and currently employs 18 full-time employees. The company went IPO on 2012-11-09. The company is developing and commercializing minimally invasive and hi-definition solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders. The company may also pursue applications for other areas such as depression, mood disorders, incontinence and artificial intelligence. Its products include Evo cortical electrode technology for recording, monitoring, and stimulating brain tissue for up to 30 days; Evo sEEG electrode technology for temporary (less than 30 days) use with recording, monitoring, and stimulation equipment for the recording, monitoring, and stimulation of electrical signals at the subsurface level of the brain, and OneRF ablation system for creation of radiofrequency lesions in nervous tissue for functional neurosurgical procedures.
Company Info
IPO: 2012-11-09
NEUROONE MEDICAL TECHNOLOGIE
7599 Anagram Dr
Eden Prairie MINNESOTA US
Employees: 18
Phone: 19524261383
NEUROONE MEDICAL TECHNOLOGIE / NMTC FAQ
What does NMTC do?
NeuroOne Medical Technologies Corp. is a medical technology company, which engages in diagnostics, ablations, and deep brain stimulation technology for brain-related conditions. The company is headquartered in Eden Prairie, Minnesota and currently employs 18 full-time employees. The company went IPO on 2012-11-09. The company is developing and commercializing minimally invasive and hi-definition solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders. The company may also pursue applications for other areas such as depression, mood disorders, incontinence and artificial intelligence. Its products include Evo cortical electrode technology for recording, monitoring, and stimulating brain tissue for up to 30 days; Evo sEEG electrode technology for temporary (less than 30 days) use with recording, monitoring, and stimulation equipment for the recording, monitoring, and stimulation of electrical signals at the subsurface level of the brain, and OneRF ablation system for creation of radiofrequency lesions in nervous tissue for functional neurosurgical procedures.
Can you provide the latest stock price for NEUROONE MEDICAL TECHNOLOGIE?
The current stock price of NMTC is 4.45 USD. The price increased by 501.35% in the last trading session.
Does NEUROONE MEDICAL TECHNOLOGIE pay dividends?
NMTC does not pay a dividend.
What is the ChartMill rating of NEUROONE MEDICAL TECHNOLOGIE stock?
NMTC has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
Can you provide the growth outlook for NEUROONE MEDICAL TECHNOLOGIE?
The Revenue of NEUROONE MEDICAL TECHNOLOGIE (NMTC) is expected to grow by 28.8% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
What is the market capitalization of NMTC stock?
NEUROONE MEDICAL TECHNOLOGIE (NMTC) has a market capitalization of 225.57M USD. This makes NMTC a Micro Cap stock.
What is the next earnings date for NMTC stock?
NEUROONE MEDICAL TECHNOLOGIE (NMTC) will report earnings on 2026-05-07.